263 related articles for article (PubMed ID: 21742012)
1. Separate and combined effects of low dose ketamine and nicotine on behavioural and neural correlates of sustained attention.
Knott VJ; Millar AM; McIntosh JF; Shah DK; Fisher DJ; Blais CM; Ilivitsky V; Horn E
Biol Psychol; 2011 Sep; 88(1):83-93. PubMed ID: 21742012
[TBL] [Abstract][Full Text] [Related]
2. Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia.
D'Souza DC; Ahn K; Bhakta S; Elander J; Singh N; Nadim H; Jatlow P; Suckow RF; Pittman B; Ranganathan M
Biol Psychiatry; 2012 Nov; 72(9):785-94. PubMed ID: 22717030
[TBL] [Abstract][Full Text] [Related]
3. Neural effects of nicotine during auditory selective attention in smokers: an event-related potential study.
Knott V; Blais C; Scherling C; Camarda J; Millar A; Fisher D; McIntosh J
Neuropsychobiology; 2006; 53(3):115-26. PubMed ID: 16601362
[TBL] [Abstract][Full Text] [Related]
4. Effects of transdermal nicotine on prose memory and attention in smokers and nonsmokers.
Poltavski DV; Petros T
Physiol Behav; 2005 Jan; 83(5):833-43. PubMed ID: 15639169
[TBL] [Abstract][Full Text] [Related]
5. Effects of the cholinergic agonist nicotine on reorienting of visual spatial attention and top-down attentional control.
Thiel CM; Fink GR
Neuroscience; 2008 Mar; 152(2):381-90. PubMed ID: 18272290
[TBL] [Abstract][Full Text] [Related]
6. Neural effects of acute nicotinic treatment on visual spatial attention in non-smokers.
Shah D; Impey D; Chique-Alfonzo M; Fisher D; Lorenzo-López L; Knott V
Pharmacol Biochem Behav; 2011 Dec; 100(2):228-36. PubMed ID: 21889951
[TBL] [Abstract][Full Text] [Related]
7. Acute nicotine fails to alter event-related potential or behavioral performance indices of auditory distraction in cigarette smokers.
Knott VJ; Scherling CS; Blais CM; Camarda J; Fisher DJ; Millar A; McIntosh JF
Nicotine Tob Res; 2006 Apr; 8(2):263-73. PubMed ID: 16766419
[TBL] [Abstract][Full Text] [Related]
8. Light up and see: enhancement of the visual mismatch negativity (vMMN) by nicotine.
Fisher DJ; Scott TL; Shah DK; Prise S; Thompson M; Knott VJ
Brain Res; 2010 Feb; 1313():162-71. PubMed ID: 20006592
[TBL] [Abstract][Full Text] [Related]
9. Ketamine effects on brain function--simultaneous fMRI/EEG during a visual oddball task.
Musso F; Brinkmeyer J; Ecker D; London MK; Thieme G; Warbrick T; Wittsack HJ; Saleh A; Greb W; de Boer P; Winterer G
Neuroimage; 2011 Sep; 58(2):508-25. PubMed ID: 21723949
[TBL] [Abstract][Full Text] [Related]
10. Baseline-dependent modulating effects of nicotine on voluntary and involuntary attention measured with brain event-related P3 potentials.
Knott V; Choueiry J; Dort H; Smith D; Impey D; de la Salle S; Philippe T
Pharmacol Biochem Behav; 2014 Jul; 122():107-17. PubMed ID: 24690514
[TBL] [Abstract][Full Text] [Related]
11. Nicotine and smoker status moderate brain electric and mood activation induced by ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist.
Knott V; McIntosh J; Millar A; Fisher D; Villeneuve C; Ilivitsky V; Horn E
Pharmacol Biochem Behav; 2006 Sep; 85(1):228-42. PubMed ID: 17023037
[TBL] [Abstract][Full Text] [Related]
12. Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits.
Poltavski DV; Petros T
Physiol Behav; 2006 Mar; 87(3):614-24. PubMed ID: 16466655
[TBL] [Abstract][Full Text] [Related]
13. Chronic nicotine interactions with clozapine and risperidone and attentional function in rats.
Rezvani AH; Caldwell DP; Levin ED
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):190-7. PubMed ID: 16310917
[TBL] [Abstract][Full Text] [Related]
14. Haloperidol counteracts the ketamine-induced disruption of processing negativity, but not that of the P300 amplitude.
Oranje B; Gispen-de Wied CC; Westenberg HG; Kemner C; Verbaten MN; Kahn RS
Int J Neuropsychopharmacol; 2009 Jul; 12(6):823-32. PubMed ID: 19154656
[TBL] [Abstract][Full Text] [Related]
15. Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.
Hamilton HK; D'Souza DC; Ford JM; Roach BJ; Kort NS; Ahn KH; Bhakta S; Ranganathan M; Mathalon DH
Schizophr Res; 2018 Jan; 191():87-94. PubMed ID: 28711472
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological evidence of nicotine's distracter-filtering properties in non-smokers.
Knott V; Heenan A; Shah D; Bolton K; Fisher D; Villeneuve C
J Psychopharmacol; 2011 Feb; 25(2):239-48. PubMed ID: 19939874
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
[TBL] [Abstract][Full Text] [Related]
18. Effects of nicotine and mecamylamine on choice accuracy in an operant visual signal detection task in female rats.
Rezvani AH; Bushnell PJ; Levin ED
Psychopharmacology (Berl); 2002 Dec; 164(4):369-75. PubMed ID: 12457266
[TBL] [Abstract][Full Text] [Related]
19. Effects of acute nicotine on brain function in healthy smokers and non-smokers: estimation of inter-individual response heterogeneity.
Ettinger U; Williams SC; Patel D; Michel TM; Nwaigwe A; Caceres A; Mehta MA; Anilkumar AP; Kumari V
Neuroimage; 2009 Apr; 45(2):549-61. PubMed ID: 19159693
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of glucose tablets on craving, withdrawal symptoms, and sustained attention in 12-h abstinent tobacco smokers.
Harakas P; Foulds J
Psychopharmacology (Berl); 2002 May; 161(3):271-7. PubMed ID: 12021830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
